Johnson & Johnson announced it will invest $2 billion over the next decade to expand its U.S. biopharmaceutical manufacturing capacity, with a major new facility in North Carolina forming the centerpiece of the initiative. The company will establish a 160,000-square-foot manufacturing facility…